| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Principal Accounting Officer
1 company
James Kihara is Principal Accounting Officer at ACAD. James Kihara's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $269K at current prices.
Historically, James Kihara's trades have earned a middling insider score of 61/100 across 26 rated trades. Over a 12-month horizon, 64.7% of those trades were profitable, with an average 12-month return of +6.2%.
The ACAD filings lean toward selling, a net 57,688 shares.
James Kihara has 31 Form 4 filings on record from February 2021 to June 2026, all as Principal Accounting Officer at ACADIA Pharmaceuticals (ACAD), 2021–2026.
The 68 reported transactions were 29 open-market sales, 25 option exercises and 14 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 25 sales worth about $1.3M.
The largest open-market sale was 11,421 shares of ACAD at an average $26.08 on June 26, 2026, about $298K.
5 of the 22 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 17 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | ACAD Acadia Pharmaceuticals Inc. | Principal Accounting Officer | Sell10b5-1 | 11,421 | $26.08 | $297,912.22 | -46.6% | -12.4% | - | |
| May 26, 2026 | ACAD Acadia Pharmaceuticals Inc. | Principal Accounting Officer | Sell | 5,401 | $21.18 | $114,393.18 | -18.1% | +39.5% | - | |
| May 4, 2026 | ACAD Acadia Pharmaceuticals Inc. | Principal Accounting Officer | Sale+OE | 1,332 | $21.79 | $29,024.28 | -4.4% | +15.4% | - | |
| Apr 7, 2026 | ACAD Acadia Pharmaceuticals Inc. | Principal Accounting Officer | Sale+OE | 1,030 | $22.20 | $22,866.00 | -3.6% | +16.7% | - | |
| Mar 26, 2026 | ACAD Acadia Pharmaceuticals Inc. | Principal Accounting Officer | Sale+OE | 1,942 | $21.57 | $41,895.26 | -6.7% | +8.8% | - | |
| Nov 18, 2025 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 4,084 | $23.69 | $96,753.64 | -14.0% | -3.6% | - | |
| May 16, 2025 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sell10b5-1 | 4,000 | $22.50 | $90,000.00 | -16.4% | +10.2% | - | |
| May 2, 2025 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 1,327 | $14.60 | $19,374.20 | -5.3% | +59.8% | - | |
| Apr 8, 2025 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 1,028 | $14.82 | $15,234.96 | -4.4% | +48.1% | +60.0% | |
| Mar 26, 2025 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 1,095 | $17.05 | $18,669.75 | -4.9% | +31.6% | +26.1% |